There is still time to register and view Pharmacology Update 2021 featuring Arif Hussain, MD – Recent Developments in Management of Advanced Bladder and Prostate Cancer

Dr. Arif Hussain is an academic oncologist with a primary focus on urologic cancers, including prostate, bladder, kidney, and germ cell cancers. He is a trialist, having conducted approximately 70 clinical trials in various genitourinary cancers that have ranged from phase 1 to phase 3 studies - these trials have included investigator-initiated, cooperative group and industry-sponsored trials for patients with recurrent and/or advanced stages of prostate, kidney, and bladder cancers.

In addition, He has a research laboratory focused on molecular mechanisms involved in mediating resistance to anti-cancer therapies, particularly in prostate cancer. He has served as a doctoral (PhD) thesis adviser for two graduate students in the Dept of Molecular Biology and Biochemistry, on the PhD thesis committee of nine other graduate students and served as Section Editor for Current Opinion in Oncology, GU Cancers since 2009.

Register now

The webinar will remain open until April 9th. Please view the presentations, complete post-tests and take the AANP survey to obtain CE certification.

 

After April 9, we will no longer be able to issue CE credit for this program. 

 

Members will be able to view all past presentations (without CE credit) on our Members Only page.

 

Any questions, please email Lorraine Diana & Elaine Crain at TheMAAPC@gmail.com

Thank you to our Industry and Pharmaceutical partners who continue to provide us with up-to-date information, new products, and practice information (Click for more information).